---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-247130"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2022-09-19T23:59:59+00:00"
generated_at: "2026-06-23T08:57:39.370674+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Sarepta Therapeutics issues $1.13B in convertible notes, repays $585.5M term loan

## Summary
- Issued $1.13B aggregate principal of 1.25% Convertible Senior Notes due 2027 to initial purchasers including Goldman Sachs and J.P. Morgan.
- Sold $20M in notes to Michael A. Chambers Living Trust, an affiliate of board member Michael Chambers.
- Prepaid $585.5M term loan from BioPharma Credit, including $7M prepayment premium, terminating the Loan Agreement.
- Used proceeds to repurchase $150.6M of existing 1.50% Convertible Senior Notes due 2024.
- Entered capped call transactions with five counterparties to reduce potential dilution upon conversion of the notes.

## SEC filing metadata
- accession: 0001193125-22-247130
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2022-09-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312522247130/0001193125-22-247130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312522247130/d357082d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-247130
- JSON: https://secwatch.observer/filing/0001193125-22-247130.json
- Plain text: https://secwatch.observer/filing/0001193125-22-247130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.